MapLight Therapeutics, Inc.
MPLTNASDAQHealthcare● Active
$29.46
+$1.45(+5.18%)
Market Cap$23253897
P/E Ratio—
52W High$33.28
52W Low$12.24
MapLight Therapeutics, Inc. (MPLT) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · MPLT · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 |
|---|---|---|---|---|
| Revenue | ||||
| Revenue | $0.00B | $0.00B | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B | $0.00B | $0.00B |
| Gross Profit | ($0.00B) | ($0.00B) | ($0.00B) | ($0.00B) |
| Gross Margin %(computed) | — | — | — | — |
| Operating Expenses | ||||
| R&D Expenses | $0.14B | $0.07B | $0.05B | $0.03B |
| G&A Expenses | $0.00B | $0.01B | $0.01B | $0.00B |
| Total Operating Expenses | $0.17B | $0.08B | $0.06B | $0.03B |
| Operating Income | ($0.17B) | ($0.08B) | ($0.06B) | ($0.03B) |
| Operating Margin %(computed) | — | — | — | — |
| Interest Income | $0.01B | $0.00B | $0.00B | $0.00B |
| Interest Expense | $0.00B | $0.00B | $0.00B | $0.00B |
| Income Before Tax | ($0.16B) | ($0.08B) | ($0.06B) | ($0.03B) |
| Income Tax Expense | $0.00B | $0.00B | $0.00B | $0.00B |
| Net Income | ($0.16B) | ($0.08B) | ($0.06B) | ($0.03B) |
| Net Margin %(computed) | — | — | — | — |
| Per Share & EBITDA | ||||
| EPS (Basic) | $-3.66 | $-1.87 | $-1.34 | $-0.72 |
| Wtd Avg Shares | 0.04B | 0.04B | 0.04B | 0.04B |
| EBITDA | ($0.17B) | ($0.08B) | ($0.06B) | ($0.03B) |
| EBITDA Margin %(computed) | — | — | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · USD · B
Explore more MapLight Therapeutics, Inc. data
About MapLight Therapeutics, Inc. (MPLT) Income Statement
MapLight Therapeutics, Inc. (MPLT) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, MPLT reported revenue of $0.00B, gross profit of ($0.00B) (gross margin —), and net income of ($0.16B) — a net profit margin of —.
Frequently asked questions
MPLT · 4 questionsMapLight Therapeutics, Inc. (MPLT) reported revenue of $0.00B for 2025, down —% year-over-year.
MPLT revenueMPLT salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09